184 related articles for article (PubMed ID: 2965231)
1. The long-term effect of isradipine in pindolol-treated patients.
Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
[TBL] [Abstract][Full Text] [Related]
2. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
Christensen HR; Kampmann JP; Simonsen K
J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
[TBL] [Abstract][Full Text] [Related]
3. Central hemodynamics and brachial artery compliance during therapy with isradipine, a new calcium antagonist.
Andersson OK; Persson B; Widgren BR; Wysocki M
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S87-9. PubMed ID: 1695312
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
[TBL] [Abstract][Full Text] [Related]
5. Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Sievert A; Aurell M; Hansson L
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S102-4. PubMed ID: 2455104
[TBL] [Abstract][Full Text] [Related]
6. The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.
Edouard A; Dartayet B; Ruegg C; Samii K
Eur J Anaesthesiol; 1991 Sep; 8(5):351-8. PubMed ID: 1834462
[TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
Burger KJ; Dehner R
Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
Welzel D; Burger KJ; Weidinger G
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
[TBL] [Abstract][Full Text] [Related]
9. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol.
Cantor A; Cristal N
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S76-8. PubMed ID: 1695309
[TBL] [Abstract][Full Text] [Related]
10. Regression of cardiac hypertrophy in hypertensive patients by long-term treatment with isradipine.
Török E; Borbás S; Lengyel M; Zorándi A
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S79-83. PubMed ID: 1376844
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
Kirch W; Burger KJ; Weidinger G; Welzel D
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
[TBL] [Abstract][Full Text] [Related]
12. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
Burger KJ; Anlauf M
Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
[TBL] [Abstract][Full Text] [Related]
13. Isradipine: overall clinical experience in hypertension in the United States.
Miller H
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S60-4. PubMed ID: 1695305
[TBL] [Abstract][Full Text] [Related]
14. Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives.
Dzúrik R; Fetkovská N; Dvorák I; Jonás P; Markuljak I; Petr P; Kotlík I; Widimský J
Cor Vasa; 1990; 32(2 Suppl 1):42-53. PubMed ID: 1974488
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of isradipine in hypertension.
Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
[TBL] [Abstract][Full Text] [Related]
16. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
17. [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
Lohmann FW; Welzel D; Burger KJ
Arzneimittelforschung; 1993 May; 43(5):522-5. PubMed ID: 8328996
[TBL] [Abstract][Full Text] [Related]
18. [Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina].
Vogt M; Motz W; Strauer BE
Arzneimittelforschung; 1994 Dec; 44(12):1321-8. PubMed ID: 7848351
[TBL] [Abstract][Full Text] [Related]
19. Platelet aggregation and metabolic control are not affected by calcium antagonist treatment in type II diabetes mellitus.
Klauser R; Speiser P; Gisinger C; Schernthaner G; Prager R
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S93-6. PubMed ID: 1695314
[TBL] [Abstract][Full Text] [Related]
20. Propranolol-hydralazine combination in essential hypertension.
Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]